Michael Buitron
banner
buitron.bsky.social
Michael Buitron
@buitron.bsky.social
HIV research and services for over 30 years. #PLWH #UequalsU #HIV testing, PrEP, educator, group facilitator, writer
A few days ago I attended a physician's dinner hosted by Gilead to promote Descovy. The presenter pointed out that the drug is only approved for cis men and trans women. When the drug was first approved, they talked about it being too expensive to run clinical trials in women, DT low incidence
November 14, 2024 at 11:36 PM
Overall, ARV drug resistance is ⬇️. In the early days it was much more common. We were prescribed 1 then 2 drug ARVs that would work for a short while.

The virus wasn’t totally suppressed so HIV could mutate and resistance would emerge.

With the advent of INSTIs, HIV has a more difficult barrier.
November 7, 2024 at 5:24 PM
In my newly diagnosed HIV+ peer support group there were plenty of guys who knew about PrEP but never got around to getting it.

Also working as a PrEP navigator I had patients stop PrEP when they were in a relationship then came back a year later being HIV+.

Us humans are bad at estimating risk
November 7, 2024 at 5:17 PM